Works matching IS 14783223 AND DT 2023 AND VI 43 AND IP 6

Results: 24

Association between antihypertensive drugs and hepatocellular carcinoma: A trans‐ancestry and drug‐target Mendelian randomization study.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1320, doi. 10.1111/liv.15566

By:

Wang, Zhenqian;
Lu, Jiawen;
Hu, Jingyi

Publication type:

Article

Toll‐like receptor 7 agonist, GS‐986, is an immune‐stimulant inducing follicular helper T cells and expanding HBs antigen‐specific B cells in vitro.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1213, doi. 10.1111/liv.15568

By:

Mori, Taizo;
Yoshio, Sachiyo;
Yoshikawa, Shiori;
Tsustui, Yuriko;
Sakata, Toshihiro;
Yoshida, Yuichi;
Sakamoto, Yuzuru;
Kawai, Hironari;
Osawa, Yosuke;
Yamazoe, Taiji;
Aoki, Yoshihiko;
Fletcher, Simon P.;
Kanto, Tatsuya

Publication type:

Article

Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1360, doi. 10.1111/liv.15567

By:

Boeckmans, Joost;
Schattenberg, Jörn M.

Publication type:

Article

Novel urinary protein panels for the non‐invasive diagnosis of non‐alcoholic fatty liver disease and fibrosis stages.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1234, doi. 10.1111/liv.15565

By:

Feng, Gong;
Zhang, Xiaoxun;
Zhang, Liangjun;
Liu, Wen‐Yue;
Geng, Shi;
Yuan, Hai‐Yang;
Sha, Jun‐Cheng;
Wang, Xiao‐Dong;
Sun, Dan‐Qin;
Targher, Giovanni;
Byrne, Christopher D.;
Zheng, Tian‐Lei;
Ye, Feng;
Zheng, Ming‐Hua;
Chai, Jin

Publication type:

Article

Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertension.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1183, doi. 10.1111/liv.15559

By:

Turco, Laura;
Reiberger, Thomas;
Vitale, Giovanni;
La Mura, Vincenzo

Publication type:

Article

Reply to: "Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank".

Published in:

Liver International, 2023, v. 43, n. 6, p. 1362, doi. 10.1111/liv.15598

By:

Tavaglione, Federica;
Jamialahmadi, Oveis;
Ljungman, Charlotta;
Romeo, Stefano

Publication type:

Article

Non‐tuberculous mycobacteriosis of the liver responsive to empiric therapy.

Published in:

2023

By:

Siciliani, Luisa;
Vanoli, Alessandro;
Berton, Francesca;
Mondelli, Mario U.

Publication type:

Case Study

Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1332, doi. 10.1111/liv.15589

By:

Park, Jae Hyon;
Park, Young Nyun;
Kim, Myeong‐Jin;
Park, Mi‐Suk;
Choi, Jin‐Young;
Chung, Yong Eun;
Rhee, Hyungjin

Publication type:

Article

Behavioural activity pattern, genetic factors, and the risk of nonalcoholic fatty liver disease: A prospective study in the UK Biobank.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1287, doi. 10.1111/liv.15588

By:

Ge, Xinyuan;
Wang, Xiao;
Yan, Yuqian;
Zhang, Lu;
Yu, Chengxiao;
Lu, Jing;
Xu, Xin;
Gao, Jiaxin;
Liu, Maojie;
Jiang, Tao;
Ke, Bibo;
Song, Ci

Publication type:

Article

Right and left liver lobe biopsies by minilaparoscopy reveal clinically significant sampling error in staging and grading of autoimmune hepatitis.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1269, doi. 10.1111/liv.15583

By:

Johannes, Hartl;
Malte, Wehmeyer;
Shaima, Alali;
Marcial, Sebode;
Sören, Weidemann;
Anastasiya, Ptashynska;
Christina, Weiler‐Normann;
Christoph, Schramm;
Willhelm, Lohse Ansgar;
Till, Krech;
Jörg, Schrader

Publication type:

Article

Carvedilol, probably the β‐blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!

Published in:

Liver International, 2023, v. 43, n. 6, p. 1154, doi. 10.1111/liv.15582

By:

Villanueva, Càndid;
Tripathi, Dhiraj

Publication type:

Article

Overcoming the challenges of eliminating viral hepatitis in low‐ and middle‐income countries.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1365, doi. 10.1111/liv.15574

By:

Vyas, Ashish Kumar

Publication type:

Article

Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis‐related liver disease: A multi‐center study validated by liver biopsy.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1277, doi. 10.1111/liv.15572

By:

Sakhuja, Shruti;
Staples, Heather M.;
Minard, Charles G.;
Ramm, Louise E.;
Lewindon, Peter J.;
Ramm, Grant A.;
Leung, Daniel H.

Publication type:

Article

Hepatocytic ballooning in non‐alcoholic steatohepatitis: Dilemmas and future directions.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1170, doi. 10.1111/liv.15571

By:

Li, Yang‐Yang;
Zheng, Tian‐Lei;
Xiao, Shu‐Yuan;
Wang, Peng;
Yang, Wen‐Jun;
Jiang, Li‐Lin;
Chen, Li‐Li;
Sha, Jun‐Cheng;
Jin, Yi;
Chen, Sui‐Dan;
Byrne, Christopher D.;
Targher, Giovanni;
Li, Jian‐Min;
Zheng, Ming‐Hua

Publication type:

Article

Hepatitis C screening and detection program in a large population: Epidemiological transition and characterization of the disease.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1225, doi. 10.1111/liv.15570

By:

Kershenobich, David;
Higuera‐de‐la Tijera, Fatima;
Flores, Nayelli;
Cerda‐Reyes, Eira;
Castro‐Narro, Graciela;
Aceves, Guillermo;
Ruiz‐Lujan, Rodolfo;
Ramos‐Medina, Salvador;
Linares, Jesus;
Azamar‐Alonso, Amilcar;
Mendez‐Navarro, Jorge;
Chirino‐Sprung, Ruby

Publication type:

Article

Low risk of viral hepatitis amongst patients with severe mental disorders.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1204, doi. 10.1111/liv.15569

By:

Fernández, Tábatha;
Plana, Teresa;
Tardón, Laia;
Marco, Oriol;
Navarro, Lourdes;
Bartrés, Concepció;
Colom, Joan;
Goikolea, José Manuel;
Cavero, Myriam;
Pacchiarotti, Isabella;
Lens, Sabela;
Forns, Xavier;
Martín‐Santos, Rocío;
Mariño, Zoe

Publication type:

Article

Spermidine suppresses the activation of hepatic stellate cells to cure liver fibrosis through autophagy activator MAP1S.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1307, doi. 10.1111/liv.15558

By:

Shi, Boyun;
Wang, Wei;
Ye, Mengting;
Liang, Min;
Yu, Ziyu;
Zhang, Yingying;
Liu, Zhaoyu;
Liang, Xue;
Ao, Jian;
Xu, Fengfeng;
Xu, Guibin;
Jiang, Xianhan;
Zhou, Xinke;
Liu, Leyuan

Publication type:

Article

Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK Biobank.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1247, doi. 10.1111/liv.15556

By:

Jamialahmadi, Oveis;
Tavaglione, Federica;
Rawshani, Araz;
Ljungman, Charlotta;
Romeo, Stefano

Publication type:

Article

Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patients.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1195, doi. 10.1111/liv.15550

By:

Nguyen, Vy H.;
Huang, Daniel Q.;
Le, Michael H.;
Jin, Michelle;
Lee, Eunice Y.;
Henry, Linda;
Nerurkar, Sanjna N.;
Ogawa, Eiichi;
Thin, Khin N.;
Teng, Margaret L. P.;
Goh, Kang S.;
Kai, Justin C. Y.;
Wong, Connie;
Tan, Darren J. H.;
Thuy, Le T. T.;
Hai, Hoang;
Enomoto, Masaru;
Cheung, Ramsey;
Nguyen, Mindie H.

Publication type:

Article

Subclinical liver traits are associated with structural and hemodynamic brain imaging markers.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1256, doi. 10.1111/liv.15549

By:

Yilmaz, Pinar;
Alferink, Louise J. M.;
Cremers, Lotte G. M.;
Murad, Sarwa D.;
Niessen, Wiro J.;
Ikram, M. Arfan;
Vernooij, Meike W.

Publication type:

Article

Transcriptomics confirm the establishment of a liver‐immune dual‐humanized mouse model after transplantation of a single type of human bone marrow mesenchymal stem cell.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1345, doi. 10.1111/liv.15546

By:

Sun, Suwan;
Yang, Hui;
Xin, Jiaojiao;
Yao, Heng;
Yuan, Lunzhi;
Ren, Keke;
Jiang, Jing;
Shi, Dongyan;
Li, Jun;
Zhou, Qian;
An, Zhanglu;
Guo, Beibei;
Chen, Jiaxian;
He, Lulu;
Liang, Xi;
Cheng, Tong;
Xia, Ningshao

Publication type:

Article

Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult‐to‐treat spontaneous bacterial peritonitis: A randomized controlled trial.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1298, doi. 10.1111/liv.15534

By:

Prakash, Vikash;
Arora, Vinod;
Jindal, Ankur;
Maiwall, Rakhi;
Sarin, Shiv Kumar

Publication type:

Article

Future anti‐HDV treatment strategies, including those aimed at HBV functional cure.

Published in:

Liver International, 2023, v. 43, n. 6, p. 1157, doi. 10.1111/liv.15387

By:

Tan, Yong Chuan;
Lee, Guan Huei;
Huang, Daniel Q.;
Lim, Seng Gee

Publication type:

Article

Issue Information.

Published in:: Liver International, 2023, v. 43, n. 6, p. 1149, doi. 10.1111/liv.15303
Publication type:: Article